Upgrade to SI Premium - Free Trial

Johnson & Johnson (JNJ) PT Raised to $185 at Raymond James

January 26, 2022 4:09 AM
Raymond James analyst Jayson Bedford raised the price target on Johnson & Johnson (NYSE: JNJ) to $185.00 (from $178.00) while maintaining a Outperform rating.

Categories

Analyst PT Change

Next Articles